Cyclooxygenase-2–Carbonic Anhydrase IX regulatory axis (COX-2–CAIX axis)

The Cyclooxygenase-2–Carbonic Anhydrase IX (COX-2–CAIX) regulatory axis is a functional signaling link between two enzymes that are frequently overexpressed in the hypoxic regions of solid tumors. Cyclooxygenase-2 (COX-2) facilitates the production of Prostaglandin E2, which has been shown to upregulate the expression of Carbonic Anhydrase IX (CAIX) through the HIF-1α and PKA signaling pathways (Ibrahim et al., 2017, PubMed: 28415615). CAIX is a transmembrane enzyme that maintains an alkaline intracellular pH while acidifying the extracellular environment, a process that promotes tumor cell survival, invasion, and resistance to therapy (Supuran, 2017, Journal of Enzyme Inhibition and Medicinal Chemistry). This axis serves as a critical driver of the epithelial-mesenchymal transition (EMT) and metastatic progression in various cancers, including breast and colorectal carcinomas. Therapeutic strategies targeting this axis often involve the combination of COX-2 inhibitors like Celecoxib and CAIX-specific inhibitors like SLC-0111 to synergistically reduce tumor growth and enhance the efficacy of conventional treatments (McDonald et al., 2019, Nature Communications). Monitoring the co-expression of these markers is considered a valuable prognostic tool for identifying aggressive tumor phenotypes. The axis represents a convergence of inflammatory and hypoxic signaling, making it a potent target for disrupting the tumor microenvironment.

Other names

PTGS2-CA9 axisCOX-2/CAIX signaling pathwayCyclooxygenase-2/Carbonic Anhydrase 9 axis

Dual inhibition of the COX-2-mediated upregulation of CAIX and the subsequent enzymatic activity of CAIX, thereby disrupting pH homeostasis and prostaglandin signaling in the tumor microenvironment.